Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)	Preferred Stock [Member] Series A Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Shares [Member]	Parent [Member]	Noncontrolling Interest [Member]	Total
Balance at Dec. 31, 2021	$ 140	$ 307,045	$ 164,517,634	$ (141,921,085)	$ (163,701)	$ 22,740,033	$ (1,031,745)	$ 21,708,288
Balance, shares at Dec. 31, 2021	1,400,000	30,704,434
Stock compensation expense		$ 3,062	13,731,552			13,734,614		13,734,614
Stock compensation expense, shares		306,250
Exercise of stock options		$ 904	89,496			90,400		$ 90,400
Exercise of stock options, shares		90,400						90,400
Exercise of warrants		$ 220	38,280			38,500		$ 38,500
Exercise of warrants, shares		22,000
Cashless exercise of stock options		$ 297	(297)
Cashless exercise of stock options, shares		29,691
Stock issued for legal settlement		$ 4,000	812,000			816,000		816,000
Stock issued for legal settlement, shares		400,000
Series A Preferred Stock dividends				(3,106,250)		(3,106,250)		(3,106,250)
Distribution to non-controlling interest							(144,000)	(144,000)
Adjustment of membership interest in WorkSimpli			(173,415)			(173,415)	185,565	12,150
Net (loss) income				(45,535,659)		(45,535,659)	514,632	$ (45,021,027)
Cashless exercise of warrants, shares		79,330
Stock issued for noncontingent consideration payment, shares		1,068,926
Stock issued for legal settlement, shares		100,000						400,000
Sale of common stock under ATM, net, shares		1,009,907
Stock issued for debt conversion, shares		672,042
Common stock issued to Medifast, shares		1,224,425						306,250
Series B Preferred Stock conversion, shares		1,560,864
Balance at Dec. 31, 2022	$ 140	$ 315,528	179,015,250	(190,562,994)	(163,701)	(11,395,777)	(475,548)	$ (11,871,325)
Balance, shares at Dec. 31, 2022	1,400,000	31,552,775
Stock compensation expense		$ 9,785	12,479,558			12,489,343		12,489,343
Stock compensation expense, shares		978,500
Exercise of stock options		$ 375	94,125			94,500		$ 94,500
Exercise of stock options, shares		37,500						37,500
Cashless exercise of stock options		$ 744	(744)
Cashless exercise of stock options, shares		74,372
Series A Preferred Stock dividends				(3,106,250)		(3,106,250)		(3,106,250)
Distribution to non-controlling interest							(144,000)	(144,000)
Adjustment of membership interest in WorkSimpli			(229,025)			(229,025)	(76,600)	(305,625)
Net (loss) income				(20,595,992)		(20,595,992)	2,756,935	(17,839,057)
Cashless exercise of warrants		793	(793)
Stock issued for noncontingent consideration payments		10,689	2,557,311			2,568,000		2,568,000
Stock issued for legal settlement		1,000	531,000			532,000		532,000
Warrants issued with debt instrument			873,100			873,100		873,100
Sale of common stock under ATM, net		10,099	6,192,560			6,202,659		6,202,659
Stock issued for debt conversion		6,720	993,280			1,000,000		1,000,000
Common stock issued to Medifast		12,244	9,987,756			10,000,000		10,000,000
Series B Preferred Stock conversion		15,609	5,057,205			5,072,814		5,072,814
Balance at Dec. 31, 2023	$ 140	$ 383,586	$ 217,550,583	$ (214,265,236)	$ (163,701)	$ 3,505,372	$ 2,060,787	$ 5,566,159
Balance, shares at Dec. 31, 2023	1,400,000	38,358,641